Skip to main content
Premium Trial:

Request an Annual Quote

Sunquest Acquires GeneInsight

NEW YORK (GenomeWeb) – Laboratory software developer Sunquest Information Systems announced today that it has acquired GeneInsight, a Boston-based developer of clinical genome interpretation and reporting software. 

GeneInsight's platform "is the most clinically-proven platform on the market and advances our ability to deliver a complete and integrated workflow for both inherited and somatic testing efforts," Sunquest President Matthew Hawkins said in a statement. "We will continue to invest in GeneInsight and introduce additional solutions that advance molecular and genomic-based diagnostics."

In late 2014, Sunquest struck a deal with GeneInsight parent company Partners Healthcare to provide genetic testing workflow capabilities to clinical geneticists and pathologists. As part of that arrangement, Sunquest made an undisclosed equity investment in GeneInsight.

With the acquisition, GeneInsight will become a wholly owned subsidiary of Sunquest. Additional terms were not disclosed. 

"GeneInsight's goal is to provide clinicians and laboratories with the ability to constantly improve clinical genetic processes and enable deeper cross-organizational communication for the benefit of patients," Sandy Aronson, executive director of IT at Partners' personalized medicine unit, said in the statement. "Sunquest will bring the GeneInsight solution to far more institutions, furthering its integration into pathology workflows and, by doing so, enable it to help many more people."